← All indications
Antigens, CD19
Differentiation antigens expressed on B-lymphocytes and B-cell precursors. They are involved in regulation of B-cell proliferation.
Drugs by status
Phase 2 trials (17)
- allogeneic natural killer cells
- blinatumomab
- pembrolizumab
- carmustine
- cyclophosphamide
- cd19 car-t cells
- autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing t lymphocytes
- car-t targeted cd19/cd20/cd22/cd30
- fludarabine
- rituximab
- etoposide
- sargramostim
- cytarabine
- melphalan
- autologous cd19/cd22 chimeric antigen receptor t-cells
- humanized cd19 car-t cells with crs suppression technology
- decitabine-primed tandem car19/20 engineered t cells
Phase 1 trials (3)